[1] Robinson WP, Van Der Linden SM, Khan MA, et al. HLA–Bw60 increases susceptibility to ankylosing spondylitis in HLA–B27+ patients. Arthritis Rheum. 1989;32(9): 1135-1141.[2] Nahal SR, Richard CM, Barthelot JM, et al. The familial form of spondyloarthropathy: a clinical study of 115 multiplex families. Arthritis Rheum. 2000;43:1356-1365.[3] Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in balb/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheumatol. 1987, 30(3):306–318.[4] Martínez A, Pachecotena C, Vázquezmellado J, et al. Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis. 2004;63(10): 1338-1340.[5] 陈慰峰.医学免疫学[M].北京:人民卫生出版社,2004:53-63. [6] Krimpenfort P, Rudenko G, Hochstenbach F, et al. Crosses of two independently derived transgenic mice demonstrate functional complementation of the genes encoding heavy (HLA-B27) and light (beta 2-microglobulin) chains of HLA class I antigens. Embo J. 1987; 6(6):1673-1676.[7] Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and humanβ 2 m: an animal model of HLA-B27-associated human disorders. Cell. 1990;63(5): 1099-1112.[8] Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.J Exp Med. 1995;182(4): 1153-1158.[9] Dangoria NS, DeLay ML, Kingsbury DJ, et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem. 2002;277(26): 23459-23468.[10] Kollnberger S, Bird LA, Roddis M, et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol. 2004;173(3): 1699-1710.[11] Zhang Y, Shi S, Ciurli C, et al. Animal models of ankylosing spondylitis.Curr Rheum Rep. 2002;4(6): 507-512.[12] [12]Weinreich S, Eulderink F, Capkova J, et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Human Immunol. 1995;42(2): 103-115.[13] Allen H, Fraser J, Flyer D, et al. Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. Proc Nat Acad Sci. 1986;83(19): 7447-7451.[14] Taurog JD, Maika SD, Simmons WA, et al. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol. 1993; 150(9):4168-4178.78.[15] Rosenbaum JT, Davey MP. Time for a gut check: Evidence for the hypothesis that HLA–B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum.2011; 63(11):3195-3198.[16] Bardos T, Szabo Z, Czipri M, et al. A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann Rheum Dis. 2005;64(7): 981-987.[17] Zhang Y, Guerassimov A, Leroux J, et al. Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes. J Clin Invest. 1998;101(8):1678-1686.[18] Adarichev VA, Glant TT. Experimental spondyloarthropathies: animal models of ankylosing spondylitis. Curr Rheumatol Rep. 2006;8(4): 267-274.[19] Capkova J, Hrncir T, Kubatova A, et al. Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10. BR male mice: The potential role of interleukin-10. BMC Musculoskelet Disord. 2012;13(1): 110.[20] Kontoyiannis D, Pasparakis M, Pizarro TT, et al. Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements : Implications for Joint and Gut-Associated Immunopathologies. Immunity. 1999;10(3):387-398.[21] Braem K, Lories RJ. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models. Joint Bone Spine. 2012;79(3): 243-248.[22] Kontoyiannis D, Pasparakis M, Pizarro TT, et al. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999;10(3): 387-398.[23] Zhang JR, Liu XJ, Xu WD, et al. Effects of tumor necrosis factor-α inhibitors on new bone formation in ankylosing spondylitis. Joint Bone Spine. 2015;83(3):257-264.[24] Machado MA, Barbosa MM, Almeida AM, et al. Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis. Rheumatol Int. 2013;33(9):2199-2213.[25] Lories RJ, Matthys P, De Vlam K, et al. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis. 2004;63(5): 595-598.[26] Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005; 115(6): 1571-1579.[27] Waite KA, Eng C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-β family. Nat Rev Genet. 2003;4(10):763-773.[28] Krug HE, Taurog JD. HLA-B27has no effect on the phenotypic expression of progressive ankylosis in ank/ank mice. J Rheumatol. 2000;27(5): 1257-1259.[29] 李维, 吴强. HLA-B27 亚型及其与强直性脊柱炎关系的研究进展[J]. 免疫学杂志, 2002, 18(B06): 191-194.[30] Jobanputra P, Choy EH, Kingsley GH, et al. Cellular immunity to cartilage proteoglycans: relevance to the pathogenesis of ankylosing spondylitis. Ann Rheum Dis. 1992;51(8): 959-962.[31] Zou J, Zhang Y, Thiel A, et al. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis. Rheumatology. 2003;42(7): 846-855.[32] Sung IH, Kim TH, Bang SY, et al. IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol. 2009;36(5): 1003-1005.[33] 王昊, 阎小萍, 孔维萍,等.补肾强督方对强直性脊柱炎患者骨质疏松及骨量减少的影响[J].中国中西医结合杂志, 2011,31(4): 471-474.[34] Glatigny S, Fert I, Blaton MA, et al. Proinflammatory T helper 17 cells are expanded and induced by dendritic cells in spondyloarthritis-prone HLA-B27 transgenic rat. Arthritis Rheum. 2012;64(1):110-120.[35] Zeng L,Lindstrom MJ.Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response.Arthritis Rheum. 2011;63:3807-3817.[36] 刘毅,蔡醒华. 肠道炎症及细菌感染在强直性脊柱炎发病中的作用[J].中华内科杂志,1995,34(5): 337-338.[37] Braem K, Lories RJ. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models. Joint Bone Spine. 2012;79(3): 243-248. |